Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 11Recruiting 3Not yet recruiting 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1CNS 1

Conditions

Ovarian Neoplasms 1Glioma 1Frailty 1Endometrial Neoplasms 1Caregiving for Cancer 1Brain Neoplasms 1

Interventions

pembrolizumab 551Specimen Handling 465Carboplatin 441Magnetic Resonance Spectroscopy 430Cyclophosphamide 412Cisplatin 397Radiotherapy 313Gemcitabine 309Bevacizumab 307Paclitaxel 294Biopsy 261Drug Therapy 249Capecitabine 242Oxaliplatin 239fludarabine 237Nivolumab 224venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 187Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 146durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Interventional × Psychosocial Intervention × Clear all
NCT04789694 2026-03-19

PHOCUS

Charles University, Czech Republic

Phase 3 Recruiting
64 enrolled
Gynecologic

Frailty, Ovarian Neoplasms, Endometrial Neoplasms

NCT07139769 2025-12-05

RAISE

Massachusetts General Hospital

Phase NA Recruiting
48 enrolled

Caregiving for Cancer

NCT06099743 2025-07-14

ASCENT Intervention for Brain Tumor Patients

Massachusetts General Hospital

Phase NA Recruiting
100 enrolled
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡